UMIN-CTR History
BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials
Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016782
Receipt No. R000019475
Scientific Title An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancer
Date of disclosure of the study information 2015/03/23
Last modified on 2021/06/15 14:30:18

No. Disposal Last modified on Item of update
1 Insert 2015/03/11 18:58:19
2 Update 2015/03/24 10:22:51 Last name of contact person
Last name of contact person
Division name
Address
Name of person sending information
Name of person sending information
3 Update 2015/03/24 10:24:27 Email
4 Update 2015/06/16 12:10:19 Recruitment status
5 Update 2015/10/15 19:17:36 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
Org. issuing International ID_2
6 Update 2016/09/12 09:04:56 Name of primary sponsor
Organization
7 Update 2017/06/14 19:06:42 Recruitment status
8 Update 2020/03/13 14:05:25 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL


Zip code
Organization1
Address1
Tel1
Organization
Organization
Address
Address
Tel
Email
9 Update 2020/05/21 17:02:40 Date of IRB
Last follow-up date
10 Update 2021/03/15 09:20:23 Number of participants that the trial has enrolled
11 Update 2021/03/15 09:42:17 Number of participants that the trial has enrolled
12 Update 2021/06/15 14:30:18 Last follow-up date

Contact us.